SEC 13F Intelligence

Baker Chad R / ABT

Baker Chad R’s Abbott Laboratories Position

Does Baker Chad R own Abbott Laboratories (ABT)? Yes — 106.7K shares worth $11M (+2.07% of its 13F portfolio) as of Q1 2026, down from 106.7K shares the prior filed quarter.

Position Value
$11M
Q1 2026
Shares
106.7K
% of Portfolio
+2.07%
Quarters Held
30
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $5MQ4 ’18Q1 ’19: $6MQ2 ’19: $6MQ3 ’19: $6MQ4 ’19: $7MQ4 ’19Q1 ’20: $8MQ2 ’20: $10MQ3 ’20: $11MQ4 ’20: $11MQ4 ’20Q1 ’21: $13MQ2 ’21: $12MQ3 ’21: $12MQ4 ’21: $15MQ4 ’21Q1 ’22: $12MQ2 ’22: $11MQ3 ’22: $10MQ4 ’22: $11,478Q4 ’22Q1 ’23: $11MQ2 ’23: $12MQ3 ’23: $10MQ4 ’23: $12MQ4 ’23Q1 ’24: $12MQ2 ’24: $11MQ3 ’24: $12MQ4 ’24: $12MQ4 ’24Q1 ’25: $14MQ2 ’25: $15MQ3 ’25: $14MQ4 ’25: $13MQ4 ’25Q1 ’26: $11Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026106.7K$11M+2.07%
Q4 2025106.7K$13M+2.41%
Q3 2025107.6K$14M+2.48%
Q2 2025107.7K$15M+2.72%
Q1 2025107.7K$14M+2.91%
Q4 2024107.2K$12M+2.37%
Q3 2024107.2K$12M+2.40%
Q2 2024107.2K$11M+2.33%
Q1 2024107.2K$12M+2.60%
Q4 2023107.2K$12M+2.66%
Q3 2023107.3K$10M+2.62%
Q2 2023106.7K$12M+2.75%
Q1 2023106.2K$11M+2.73%
Q4 2022104.5K$11,478+3.22%
Q3 2022104.5K$10M+2.88%
Q2 2022104.5K$11M+3.16%
Q1 2022104.5K$12M+2.79%
Q4 2021104.5K$15M+3.05%
Q3 2021104.5K$12M+2.77%
Q2 2021104.5K$12M+2.72%
Q1 2021104.5K$13M+3.00%
Q4 2020104.5K$11M+2.79%
Q3 2020104.5K$11M+3.06%
Q2 2020104.5K$10M+2.88%
Q1 2020104.5K$8M+3.20%
Q4 201975.8K$7M+2.19%
Q3 201975.8K$6M+2.26%
Q2 201975.8K$6M+2.23%
Q1 201975.8K$6M+2.19%
Q4 201875.8K$5M+2.37%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Baker Chad R’s full portfolio or all institutional holders of ABT.